Intellectual Property Rights (IPR) Coordination Center Reports Area
Operation In Our Sites specifically targets websites and their operators that distribute counterfeit and pirated items over the Internet, including counterfeit pharmaceuticals and pirated movies, television shows, music, software, electronics and other merchandise, as well as products that threaten public health and safety.
The IPR Center’s Outreach & Training Unit engages in partnerships with public and private sectors to combat Intellectual Property (IP) theft through its Operation Joint Venture (Joint Venture) initiative. This IPR Center-led outreach initiative increases information sharing with the public and private sector to combat the illegal importation and distribution of counterfeit, substandard, and tainted goods.
The IPR Center uses the expertise of its member agencies to share information, perform interdictions and conduct investigations related to intellectual property crimes. With the proliferation of counterfeit goods increasing at an alarming rate, the IPR Center focuses on keeping counterfeit products off U.S. streets while dismantling the criminal organizations behind this activity.
U.S. Immigration and Customs Enforcement (ICE) Homeland Security Investigations (HSI), in close cooperation with U.S. Customs and Border Protection (CBP), investigates commercial fraud, including false statements and deceptive business practices. ICE HSI’s commercial fraud programs unit, which is led by the National Intellectual Property Rights Coordination Center (IPR Center), prioritizes health and safety violations, U.S. economic interests and duty collection.
Documents related to learning about digital and online IP theft.
Operation Apothecary targets unapproved, counterfeit, or adulterated pharmaceuticals. Apothecary was initiated in fiscal year (FY) 2004 under the auspices of Operation Guardian to combat the growing problem of Internet crime. Particular emphasis is placed on the use of the Internet as the primary means of communication and ordering of pharmaceuticals.